Monash Phage Foundry

Monash Phage Foundry (MPF)

The Centre to Impact AMR has assembled a team of world-renowned bacteriophage (phage) experts to create a unique Monash Phage Foundry.

The MPF is supplying therapeutic phages to the clinical referral service 'Victorian Phage Therapy Service' (VicPhage) with the support of The Alfred.

We will also service other hospital partners in the Phage Australia Network and other industry sectors with phages and phage-derived products.



Monash Phage Foundry
Phage Production Facility
VICPhage
Bacteriophage Therapy Referral Service

Associate Professor Jeremy Barr

School of Biological Sciences, Faculty of Science, Monash University

Phage Biology | Phage Discovery | Phage Production for treatment of Infections

Contact:  Jeremy.Barr@monash.edu

Professor Anton Peleg

Department of Infectious Diseases,  The Alfred Hospital and Monash University

Clinical Lead | Infectious Diseases Clinician | Phage Therapy

Contact: Anton.Peleg@monash.edu

More Information

 
Monash Bacteriophage research groupsMonash Bacteriophage research groups

Professor Trevor Lithgow

Phage Discovery from under-sampled environments |  Phage genomics and structural biology |  Phage binding and adaption to bacterial surfaces | Biobanking

Professor Jian Li

Innovative phage therapy against multidrug-resistant P. aeruginosa, A. baumannii and K. pneumoniae

Associate Professor Jiangning Song

Artificial intelligence systems for phage characterization and deployment

Dr Rhys Dunstan

Artificial intelligence systems for phage characterization and deployment

Associate Professor Mike McDonald

Phage Evolution | Phage-Bacterial Host Co-Evolution | Phage resistance | Phage as a tool for microbial community engineering

Dr Tze Thung

Phage Evolution | Phage-Bacterial Host Co-Evolution | Phage resistance | Phage as a tool for microbial community engineering

Dr Sue Nang 

Development of therapeutic phages | Drug-resistant P. aeruginosa, A. baumannii and K. pneumoniae

VICPhage - Bacteriophage Therapy Referral Service

Phage therapy is an experimental method that is only available when all other approaches are already optimised and only under the auspices of a special access scheme defined by the Therapeutic Goods Administration or within a clinical trial.
If a TGA-approved indication exists, we follow a protocol that has been defined by consensus among expert physicians and may evolve over time as data are reviewed. Professor Anton Peleg, Director of Infectious Diseases at the Alfred hospital is making  Phage Therapy a reality for Victoria  patients.
At this time, Phage therapy is only available to patients meeting certain medical criteria. Referrals to Anton and his team should be made through your family doctor or an infectious diseases specialist.
The process to be eligible for treatment is below.
  1. If you believe that you or a family member may be a suitable candidate for phage therapy, please see your family doctor in the first instance to discuss this and request a referral to an adult or paediatric infectious disease specialist.
  2. If your Infection specialist can certify that all medical and surgical anti-infection strategies are optimised or exhausted, they may suggest a referral to one of our team for discussion.
  3. If you meet all are requirements and are eligible for phage therapy  there will be a requirement  that non-phage anti-infective strategies be closely and independently monitored during the course of phage therapy and there will be a  follow-up period of several weeks thereafter.
If you are eligible to receive therapy, we require informed consent and a minimum data set (including blood tests) that is necessary for the monitoring of your treatment.

Clinical Team

Professor Anton Peleg

Alfred Health and Monash University
Clinical Lead
Infectious Diseases Clinician

Contact: Anton.Peleg@monash.edu

Treatment options for multi-drug resistant bacterial infections

Dr Fernando Gordillo-Altamirano

Alfred Health and Monash University

Phage Therapy Clinical Manager

Developing a collection of therapeutically relevant bacteriophages

Standardisation of procedures to  produce therapeutic phages to treat critically ill patients

Monitoring phage-therapy treatments


News & Stories


We provide a range of solutions  to bacterial problems.

Please contact us today to discuss your project further.

Email : centreimpactamr-research@monash.edu